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• The pleura, including the mesothelial and underlying 
mesenchymal cells and extracellular matrix, is often involved 
in pathological processes of not completely defined mecha- 
nisms. Pleural cells are specialized in performing barrier and 
secretory functions and require careful study to gather a mean- 
ingful clinical information. 
A variety of agents can affect the pleura causing inflammation, 
effusions, and fibrosis. The mesothelial cells are a major source 
of chemokines (1), such as monocyte chemotactic peptide-1 
(MCP-1) and interleukin-8 (IL-8), which are mediators for cell 
migration through the pleural region (2). 
Inflammation and tumor metastasis in pleura remain a signi- 
ficant clinical problem. The role of cell adhesion molecules 
(CAM) in these processes is currently being explored. 
THE BALANCE BETWEEN MEMBRANE-BOUND AND SOLUBLE 
INTERCELLULAR ADHESION MOLECULE-1 AS A REGULATORY 
MECHANISM FOR TUMOR METASTASIS IN PLEURA 
• Intercellular adhesion molecule-1 (ICAM-1, CD54)be- 
longs to the immunoglobulin supergene family and binds the 
leukocyte function-associated antigenrl (LFA-1, CDlla/CD18). 
Tumor necrosis factor-a (TNF-cc), interferon (INF) -a, INF- 
P, andlNF-y upregulate ICAM-1 on different cell types, includ- 
ing endothelial and inflammatory cells. The soluble form of 
ICAM-1 (sICAM-1) contains the larger part of the extracellu- 
lar portion of the membrane-bound ICAM-1 (3). 
As a part of an ongoing study, we performed an immunocy- 
tochemical investigation on ICAM-1 expression on mesothe- 
lial cells in malignancy-associated pleural effusions. We found 
out that the cytological detection of malignant cells in pleural 
fluid correlates with a low percentage of ICAM-1-immunopo- 
sitive mesothelial cells (4). As a source of chemokines (2) and 
by expressing ICAM-1 as a ligand of LFA-1 (5), mesothelial 
cells participate in the migration into and accumulation of in- 
flammatory cells in the pleural cavity. It seems likely that 
sICAM-1 released in the serum retains a capacity to bind LFA- 
1. The effect may be attenuation of inflammation by inhibit- 
ing extravasation of leukocytes to inflamed tissues (6). 
Tumor cells are also known to express ICAM-1 (7, 8). Cultured 
human tumor cells treated with cytokines showed an increased 
expression of ICAM-1 and shedding into the culture medium 
(9). It was demonstrated a double increase of ICAM-1 expres- 
sion on tumor cells in pleural effusions after immunotherapy 
(8). In malignancy, the activation of T cells and monocytes or 
cytolysis of tumor cells are mediated via the receptor/ligand 
pairs CD2/LFA-3 andLFA-l/ICAM-1. Soluble forms ofLFA- 




Elevated levels of sLFA-3 and sICAM-1 in malignant effusions 
were established (10). Secretion of sICAM-1 and sLFA-3 by 
tumor cells may block T cell-mediated tumor cytotoxicity. This 
may be a mechanism for tumor cells to escape the immune sur- 
veillance (11, 12). ThelowICAM-1-immunoreactivityonme- 
sothelial cells in the presence of pleural metastasis could be ex- 
plained with the high level of sICAM-1 released by the tumor 
cells in the serum and pleural fluid which may interfere in the 
interaction between mesothelial and inflammatory cells, thus 
damaging the mesothelial barrier. 
MACROPHAGES IN THE PLEURAL CAVITY - WHERE 
THEY COME FROM AND HOW THEY PARTICIPATE IN 
THE TUMOR DEFENCE 
• The macrophages are antigen presenting cells playing 
a crucial role in nearly all types of immune responses. Blood 
monocytes interact with vascular endothelial cells expressing 
L-selectin, a4(5l integrin and P2 integrin responsible for the 
extravasation of monocytes into tissues and serosal cavities, 
where they are called macrophages (13). However, macroph- 
ages are not equivalent to mature resident body cavity cells. 
Only a small fraction of mononuclear phagocytes in effusions 
are of blood origin. It was suggested that macrophages renew 
themselves from a local pleural stem cell population and dis- 
puted whether these stem sells are mesothelial cells (14). It is 
known that LFA-1 and CD 1 Ib/CD 18 are expressed on mono- 
cyte-macrophages but not on mesothelial cells. In our study, 
we observed LFA-1- and GDI lb/CD18-immunopositive cells 
with morphological signs intermediate of macrophages and me- 
sothelial cells, in nearly all exudative or transudative pleural 
effusions. Thus we give another evidence for the hypothesis 
about a mesothelial origin of a certain clone of the pleural cavity 
macrophages (14). 
Yet another interesting point is that tumor cells of various his- 
tological types in pleural effusions have been shown to express 
high ICAM-1-immunoreactivity (7, 8). Our results show that 
a high percentage of LFA-1 and CD 1 Ib/CD 18 macrophage im- 
munopositivity correlates with the presence of malignant cells 
in pleural effusions. This suggests that tumor cell invasion in- 
duce a continuous state of p2 integrin upregulation in macroph- 
ages. We assume that via ICAM-1/P2 integrin interaction mac- 
rophages can recognize tumor cells and mediate lysis by a di- 
rect cell-to-cell, juxtacrine way. These findings arise the ques- 
tion whether the percentage of LFA-1 and CD lib/CD 18- 
immu no positive macrophages in malignant pleural effusions 
correlate with patient survival. 
DOES A COMPREHENSIVE ASSESSMENT OF CELL 
ADHESION 
MOLECULE EXPRESSION ON CELLS IN PLEURAL FLUID 
IMPROVE THE ETIOLOGICAL DIAGNOSIS 
• The results of many studies, including ours, concern- 
ing CAM expression in pleural effusions, maybe summarized 
and interpreted in the light of a definite etiology. This requires 
a complex evaluation of data from CAM expression on me- 
sothelial and inflammatory cells in different pleural diseases. 
Accordingly, in our previous work we performed a multifac- 
tor analysis of a large number of cytomorphological variables 
(15). Recently, we investigated the expression of several CAM, 
such as LFA-1, CDllb/CD18, ICAM-1, platelet-endothelial 
cell adhesion molecule-l(PECAM-l,CD31), and E-cadherin, 
on pleural fluid cells (Table 1). We measured the percentage 
of immunopositivity of a certain adhesion molecule in a cer- 
tain cell population. These variables are analyzed via discrimi- 
nating analysis. If the etiological groups of pleural effusions 
have CAM specificity it would be possible to work out differ- 
ent informants for the different etiological types. To our pre- 
liminary data of tuberculous, parapneumonic and malignant 
pleural effusions, we have worked out three informants includ- 
ing the following variables: LFA-1-immunopositive lympho- 
cytes and LFA-1-, CD1 lb/CD18- and PECAM-1-immunopo- 
sitive macrophages. Further studies should be directed to such 
a comprehensive analysis. This may provide a correct view 
about the adhesive specificity of pleural disorders and a key for 
their diagnosis, monitoring and prognosis. 
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Table 1. Panel of cell adhesion molecules (CAM) expressed 
on cells in the pleural fluid 
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